News Archive All years All months
-
EU grants EUR 6m to the clinical development of Athera´s cardiovascular disease antibody therapy
Athera Biotechnologies AB today announced that future development costs of its fully human antibody PC-mAb up until proof-of-concept will be co-funded by the European Union’s Seventh Framework Programme for Research (FP7) through a collaborative research grant. Karolinska Development AB owns 65% of Athera Biotechnologies AB. Athera’s fully human monoclonal antibody PC-mAb is targeting phosphorylcholine and [...]
-
Alzheimer’s drug reduces risk of heart attack
The risk of suffering a myocardial infarction is lower for people with Alzheimer’s disease on so-called cholinesterase inhibitors, according to a large observation study from Umeå University and Karolinska Institutet published in The European Heart Journal. Survival is also increasing amongst patients who have received this kind of drug, compared with those who have not [...]
-
Swedish Pyrosequencing inventor scoops European Inventor Award 2013
Sweden’s Dr Pål Nyrén, the inventor of pyrosequencing, has been awarded the European Patent Office’s 2013 European Inventor Award in the SME category. The prize honours outstanding inventors for their contribution to social, economic and technological progress. According to the citation, pyrosequencing and related technological advances have driven down the cost of DNA sequencing, to [...]
-
Indonesian and Swedish trade associations for life science initiates cooperation
In connection with the Indonesian state visit to Sweden, has a Memorandum of Understanding, MoU, signed between GP. Farmasi Indonesia, SwedenBIO and I3L to create greater cooperation between the Swedish and Indonesian life science industry. The agreement was signed by John Setijono, Chairman Indonesian Pharmaceutical Association and chairman Kalbe Farma; Mr. Adlersson, Vice Chairman SwedenBIO and [...]
-
Affibody AB and Daewoong Pharmaceutical Co., Ltd. enter into a License Agreement regarding the Albumod™ platform
Affibody is pleased to announce a collaboration with Daewoong Pharmaceutical Co., Ltd. Affibody AB and Daewoong Pharmaceutical Co., Ltd. have signed a License Agreement regarding the use of Affibody’s proprietary Albumod™ platform which is designed to enhance the efficacy of biopharmaceuticals by extending their circulatory half-life. The technology will be applied on one undisclosed molecule [...]
-
BIO-X® Call for proposal 2013
New opportunities for existing drugs This year, BIO-X® invites you to submit a proposal for projects suggesting new opportunities for existing drugs to provide further benefits to patients, healthcare or society. The project could be a concept test for a new general solution that could be applied to more than one drug. Or it could be [...]
-
24 May: Alumni reception in Beijing
On Friday 24 May, Uppsala University will organize an alumni reception in Beijing. The event will be held at the Grand Hyatt Hotel, 1 East Chang An Avenue, Oriental Plaza Complex, Beijing. Deputy Vice-Chancellor Anders Malmberg will be hosting the reception, and this time we will arrange the event jointly with the Matariki University Network. [...]
-
Uppsala University strengthens its American alumni network
In connection with the annual North American conference on Scandinavian Studies, Uppsala University invited alumni in the Bay Area to information and networking meeting at the Hilton Hotel in San Francisco on May 4. Nearly 50 both older and quite recent students from Uppsala University heeded the invitation – the eldest spent a year in [...]
-
EU project will increase researcher access to biobanks
All of us stand to benefit from large European health studies, but it is not always easy for researchers to collaborate across national borders. To help enable collaboration, the international EU-funded project BBMRI-LPC will spend the next four years working to increase researchers’ access to samples and data. Researchers at Uppsala University have a key [...]
-
New technology platform launched at SciLifeLab in Uppsala
An advanced chip that swiftly and with extremely high sensitivity can measure 92 different tumour proteins from 92 different patients is now available at SciLifeLab in Uppsala. The new technology will become an important resource for researchers and companies developing diagnostics for different illnesses. “In the first step the technology will primarily be used for [...]